Related Experiment Video
Updated: Jan 21, 2026

Multicolor Flow Cytometry Analyses of Cellular Immune Response in Rhesus Macaques
Published on: April 22, 2010
Cellular immune responses against cancer-germline genes in cancers
Background:
Cancer-germline genes are a class of genes that are normally expressed in testis, trophoblast and few somatic tissues but abnormally expressed in tumor tissues. Their expression signature indicates that they can induce cellular immune responses, thus being applied as targets in cancer immunotherapy.
Objectives:
To obtain the data of cellular immune responses against cancer-germline genes in cancer.
Methods:
We searched PubMed/Medline with the key words cancer-germline antigen, cancer-testis antigen, CD4+ T cell, CD8+ T cell and cancer.
Results:
About 40 cancer-germline genes have been shown to induce T cell specific responses in cancer patients. Melanoma, lung and breast cancer are among the mostly assessed cancer types. Several epitopes have been identified which can be used in immunotherapy of cancer.
Conclusion:
Cellular immune responses against cancer-germline genes are indicative of appropriateness of these genes as therapeutic targets.
Insights
Cellular immune responses against cancer-germline genes are observed in patients with melanoma, lung, and breast cancers. These findings support the use of cancer-germline genes as targets for cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
- Genetics
Background:
- Cancer-germline genes are expressed in normal tissues but abnormally in tumors.
- Their expression suggests potential for inducing anti-cancer immune responses.
- These genes are promising targets for cancer immunotherapy.
Purpose of the Study:
- To gather data on cellular immune responses to cancer-germline genes in cancer patients.
- To evaluate cancer-germline genes as targets for cancer immunotherapy.
Main Methods:
- Literature search of PubMed/Medline.
- Keywords included: cancer-germline antigen, cancer-testis antigen, CD4+ T cell, CD8+ T cell, and cancer.
Main Results:
- Approximately 40 cancer-germline genes elicit T cell responses in cancer patients.
- Melanoma, lung, and breast cancers are frequently studied.
- Identified epitopes can be utilized in cancer immunotherapy.
Conclusions:
- Cellular immune responses against cancer-germline genes confirm their suitability as therapeutic targets.
- These genes represent a viable strategy for developing novel cancer immunotherapies.
More Related Videos
Related Concept Videos
Humoral Immune Responses
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cell-mediated Immune Responses

